FDA Analysis Of Pfizer COVID-19 Vaccine Finds It Effective And Safe

The Food and Drug Administration released a detailed analysis Tuesday morning of the COVID-19 vaccine from Pfizer and its partner BioNTech ahead of a Thursday meeting of a group of independent experts that will advise the agency on whether to grant the vaccine an emergency use authorization.

The agency's analysis finds "no specific safety concerns identified that would preclude issuance of an EUA." Serious reactions were rare. Side effects are common, however, with a majority of study volunteers experiencing reactions at the site of injection, headaches and fatigue.

The analysis also affirms the previously stated vaccine effectiveness of 95%, assessed a week after two doses of vaccine. The vaccine doses are given 21 days apart.

https://www.npr.org/sections/health-shots/2020/12/08/944165524/fda-analysis-of-pfizer-covid-19-vaccine-finds-it-effective-and-safe?utm_source=npr_newsletter&utm_medium=email&utm_content=20201208&utm_term=5011155&utm_campaign=breaking-news&utm_id=48780983&orgid=309